Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Orexin in sleep, addiction and more: Is the perfect insomnia drug at hand?
Daniël Hoyer, Laura H. Jacobson
Neuropeptides (2013) Vol. 47, Iss. 6, pp. 477-488
Closed Access | Times Cited: 107

Showing 26-50 of 107 citing articles:

Neurobiological risk factors for problematic social media use as a specific form of Internet addiction: A narrative review
Sergey Tereshchenko
World Journal of Psychiatry (2023) Vol. 13, Iss. 5, pp. 160-173
Open Access | Times Cited: 13
Effects of daridorexant on rest/wake activity patterns and drinking in adult rats exposed to chronic ethanol vapor in adolescence
Leslie R. Amodeo, Derek N. Wills, Jason Benedict, et al.
Alcohol (2025)
Open Access
Orexin as a modulator of fear-related behavior: Hypothalamic control of noradrenaline circuit
Shingo Soya, Takeshi Sakurai
Brain Research (2018) Vol. 1731, pp. 146037-146037
Open Access | Times Cited: 44
Sleep Pharmacogenetics: Personalized Sleep-Wake Therapy
Sebastian C. Holst, Amandine Valomon, Hans‐Peter Landolt
The Annual Review of Pharmacology and Toxicology (2015) Vol. 56, Iss. 1, pp. 577-603
Open Access | Times Cited: 42
Redox Mechanisms in Migraine: Novel Therapeutics and Dietary Interventions
Patrizia Ferroni, Piero Barbanti, David Della‐Morte, et al.
Antioxidants and Redox Signaling (2017) Vol. 28, Iss. 12, pp. 1144-1183
Closed Access | Times Cited: 42
Effect of the new dual orexin receptor antagonist daridorexant on nighttime respiratory function and sleep in patients with mild and moderate obstructive sleep apnea
Marie‐Laure Boof, Jasper Dingemanse, Katharina Lederer, et al.
SLEEP (2020) Vol. 44, Iss. 6
Open Access | Times Cited: 33
Orexin dual receptor antagonists, zolpidem, zopiclone, eszopiclone, and cognitive research: A comprehensive dose-response meta-analysis
Mengzhen Zhou, Jiyou Tang, Shasha Li, et al.
Frontiers in Human Neuroscience (2023) Vol. 16
Open Access | Times Cited: 11
Orexin OX2 Receptor Antagonists as Sleep Aids
Laura H. Jacobson, Sui Chen, Sanjida Mir, et al.
Current topics in behavioral neurosciences (2016), pp. 105-136
Open Access | Times Cited: 35
Hypnotics with novel modes of action
Daniël Hoyer, Andrew G. Allen, Laura H. Jacobson
British Journal of Clinical Pharmacology (2019) Vol. 86, Iss. 2, pp. 244-249
Open Access | Times Cited: 33
Using the fragment molecular orbital method to investigate agonist–orexin-2 receptor interactions
Alexander Heifetz, Matteo Aldeghi, Ewa I. Chudyk, et al.
Biochemical Society Transactions (2016) Vol. 44, Iss. 2, pp. 574-581
Open Access | Times Cited: 32
Optical probing of orexin/hypocretin receptor antagonists
Shi‐Bin Li, Natalie Nevárez, William J. Giardino, et al.
SLEEP (2018) Vol. 41, Iss. 10
Open Access | Times Cited: 32
Orexin-A Regulates Follicular Growth, Proliferation, Cell Cycle and Apoptosis in Mouse Primary Granulosa Cells via the AKT/ERK Signaling Pathway
Muhammad Safdar, Aixin Liang, Shahid Ali Rajput, et al.
Molecules (2021) Vol. 26, Iss. 18, pp. 5635-5635
Open Access | Times Cited: 24
The Relationship Between Internet Usage Style and Internet Addiction and Food Addiction in Obese Children Compared to Healthy Children
Serkan Bilge Koca, Ahu Paketçi, Gönül Büyükyılmaz
Turkish Archives of Pediatrics (2023) Vol. 58, Iss. 2, pp. 205-211
Open Access | Times Cited: 9
Suvorexant, an FDA-approved dual orexin receptor antagonist, reduces oxycodone self-administration and conditioned reinstatement in male and female rats
Jessica M. Illenberger, Francisco J. Flores‐Ramirez, Alessandra Matzeu, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 9
Therapeutic implications of the choroid plexus–cerebrospinal fluid interface in neuropsychiatric disorders
Delphine Demeestere, Claude Libert, Roosmarijn E. Vandenbroucke
Brain Behavior and Immunity (2015) Vol. 50, pp. 1-13
Closed Access | Times Cited: 33
Substituted pyrrolidin-2-ones: Centrally acting orexin receptor antagonists promoting sleep. Part 2
Thierry Sifferlen, Amandine Boller, Audrey Chardonneau, et al.
Bioorganic & Medicinal Chemistry Letters (2015) Vol. 25, Iss. 9, pp. 1884-1891
Closed Access | Times Cited: 31
Clinical pharmacology of the dual orexin receptor antagonist ACT-541468 in elderly subjects: Exploration of pharmacokinetics, pharmacodynamics and tolerability following single-dose morning and repeated-dose evening administration
Clemens Muehlan, Margaux Boehler, Sander Brooks, et al.
Journal of Psychopharmacology (2019) Vol. 34, Iss. 3, pp. 326-335
Closed Access | Times Cited: 29
At the intersection of sleep deficiency and opioid use: mechanisms and therapeutic opportunities
Mark K. Greenwald, Tabitha E.H. Moses, Timothy Roehrs
Translational research (2021) Vol. 234, pp. 58-73
Open Access | Times Cited: 20
Suvorexant maintenance enhances the reinforcing but not subjective and physiological effects of intravenous cocaine in humans
William W. Stoops, Justin C. Strickland, Kevin W. Hatton, et al.
Pharmacology Biochemistry and Behavior (2022) Vol. 220, pp. 173466-173466
Open Access | Times Cited: 15
Preventive Effect of Suvorexant for Postoperative Delirium after Coronary Artery Bypass Grafting
Kiyoshi Tamura, Toshiyuki Maruyama, Syogo Sakurai
Annals of Thoracic and Cardiovascular Surgery (2018) Vol. 25, Iss. 1, pp. 26-31
Open Access | Times Cited: 24
The Orexin-A-Regulated Akt/mTOR Pathway Promotes Cell Proliferation Through Inhibiting Apoptosis in Pancreatic Cancer Cells
Linna Suo, Xiaocen Chang, Yuyan Zhao
Frontiers in Endocrinology (2018) Vol. 9
Open Access | Times Cited: 24
Orexins role in neurodegenerative diseases: From pathogenesis to treatment
Derbew Fikadu Berhe, Abadi Kahsu Gebre, Brhane Teklebrhan Assefa
Pharmacology Biochemistry and Behavior (2020) Vol. 194, pp. 172929-172929
Closed Access | Times Cited: 21
Effect of the novel dual orexin receptor antagonist daridorexant on night‐time respiratory function and sleep in patients with moderate chronic obstructive pulmonary disease
Marie‐Laure Boof, Jasper Dingemanse, Mareile Brunke, et al.
Journal of Sleep Research (2021) Vol. 30, Iss. 4
Closed Access | Times Cited: 19
History of ALS and the competing theories on pathogenesis: IFCN handbook chapter
Andrew Eisen, Steve Vucic, Hiroshi Mitsumoto
Clinical Neurophysiology Practice (2023) Vol. 9, pp. 1-12
Open Access | Times Cited: 7
The hypocretin/orexin system as a target for excessive motivation in alcohol use disorders
David E. Moorman
Psychopharmacology (2018) Vol. 235, Iss. 6, pp. 1663-1680
Open Access | Times Cited: 22

Scroll to top